JPRN-UMIN000007230
Completed
Phase 1
Retrograde isolated hepatic perfusion:Phase 1 trial - Phase 1 trial of R-IHP
ippon medical school0 sites20 target enrollmentFebruary 6, 2012
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- malignant liver neoplasm in advanced stage
- Sponsor
- ippon medical school
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1 Contraindication to angiography (due to severe side effect of contrast media) 2 High risk for general anesthesia 3 Advanced heart disease 4 Tumor invasion to Inferior vena cava or Portal vein trunk 5 Vascular anatomy not suitable for catheterization
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
The management of acute variceal bleeding in patients with liver cirrhosis at high risk of rebleeding with early placement of stent in the liver versus optimized medical therapy.Health Condition 1: K746- Other and unspecified cirrhosis ofliverCTRI/2023/11/059817All India Institute of Medical Sciences
Recruiting
Not Applicable
oninvasive Evaluation of Hepatic Hemodynamics Using Xe Computed Tomographyiver disease (acute hepatitis, Chronic hepatitis, liver cirrhosis, hepatic failure, etc) Liver tumor (hepatocellular carcinoma, cholangiocellular carcinoma, metastatic liver tumor, etc)JPRN-UMIN000008078St. Marianna University, School of Medicine, Department of Internal Medicine, Division of Gastroenterology & Hepatology1,000
Completed
Phase 1
A phase I,II trial of hepatic arterial infusion chemotherapy with cisplatin and 5-fluorouracil for unresectable advanced hepatocellular carcinomahepatocellular carcinomaJPRN-UMIN000013734Sapporo Medical University School of Medicine28
Completed
Phase 1
Phase I study of hepatic arterial infusion chemotherapy with gemcitabine and 5FU for postoperative liver metastases from pancreatic cancer.Postoperative liver metastases from pancreatic cancerJPRN-UMIN000011059Department of Gastroenterologic Surgery, Kanazawa University12
Completed
Not Applicable
Covered transjugular intrahepatic portosystemic stent shunt versus optimised medical treatment for the secondary prevention of variceal bleeding in cirrhosisISRCTN16334693Individual sponsor (Germany)186